TechGuru: thank you for an excellent discussion of the many moving parts that could play out in various ways regarding this new development regarding Vyera. I would also suggest the need for concern that FDA personnel reviewing CYDY's BLA might weigh in on Vyera's fitness to perform its commercialization role. Totally agree that its way too early to draw any firm conclusions. Thanks again.